Meilleure Health International Industry Group Limited (Meilleure Health) has filed its monthly return with Hong Kong Exchanges and Clearing Limited for the period ended 31 October 2026, indicating a stable capital structure and full compliance with public-float requirements. The filing was submitted on 2 November 2026.

Authorized and Issued Capital • Authorized share capital remained unchanged at 10.00 billion ordinary shares with a par value of HK$0.01, representing HK$100.00 million in total authorized capital. • Issued share capital also stayed flat: 4.06 billion shares were on issue, of which 4.06 billion are in public hands and 5.33 million are held as treasury shares. No new shares were issued, cancelled, or repurchased during the month.

Public Float Compliance The company confirmed adherence to the Main Board’s minimum public-float threshold of 25%, stating that the requirement was met as of 31 October 2026.

Equity Incentive Schemes 1. 2019 Share Option Scheme – Outstanding options: 16.97 million with an exercise price of HK$0.33. – Movements: No grants, exercises, cancellations, or lapses in October. – Shares that could still be issued under this plan: 16.97 million, with an additional mandate allowing up to 427.18 million future option shares.

2. 2026 Share Award Scheme – Shares that may be issued: 408.84 million. – Activity during the month: No shares were issued or transferred from treasury.

Other Instruments The company reported no outstanding warrants, convertibles, or other share-linked instruments and recorded no other share movements during the month.

Overall, Meilleure Health’s October return highlights a steady equity base with no dilution events and confirms the company’s continued compliance with Hong Kong listing regulations.